Nabriva Therapeutics Plc

NASDAQ:NBRV   11:31:26 AM EDT
0.20
0.00 (-0.71%)
Earnings Announcements

Nabriva Therapeutics Reports Fourth Quarter Revenue Of $9.3 Mln

Published: 03/29/2022 20:30 GMT
Nabriva Therapeutics Plc (NBRV) - Nabriva Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update.
Q4 Revenue $9.3 Million.
Cash Runway Extended Well Into Q4 2022.
Qtrly Loss per Share Basic and Diluted $0.24.
Revenue is expected to be $9.47 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $11.05 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.